Cibc World Market Inc. Bio N Tech Se Transaction History

Cibc World Market Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$118.43 - $186.05 $29,133 - $45,768	246 Added 15.77%	1,806 $271,000
Q3 2022 Nov 10, 2022	SELL	$127.65 - $183.11 $176,922 - $253,790	-1,386 Reduced 47.05%	1,560 $210,000
Q2 2022 Aug 10, 2022	SELL	$123.25 - $186.24 $4,560 - $6,890	-37 Reduced 1.24%	2,946 $439,000
Q1 2022 May 12, 2022	BUY	$126.25 - $231.85 $22,725 - $41,733	180 Added 6.42%	2,983 $509,000
Q4 2021 Feb 14, 2022	BUY	$216.64 - $362.52 $423,531 - $708,726	1,955 Added 230.54%	2,803 $723,000
Q3 2021 Nov 12, 2021	BUY	$205.93 - $447.23 $174,628 - $379,251	848 New	848 $231,000
Q1 2021 May 11, 2021	SELL	$85.73 - $119.5 $214,067 - $298,391	-2,497 Closed	0 $0
Q4 2020 Feb 08, 2021	BUY	$72.71 - $129.54 $181,556 - $323,461	2,497 New	2,497 $204,000

358

38.4M

2.45M

2.29M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $24.2B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Cibc World Market Inc., based on Form 13F filings with the SEC.

Stay updated on Cibc World Market Inc. with notifications on news.